Mohammed Nabil Quraishi

17PUBLICATIONS
42CO-AUTHORS
NeonatologyCancer therapy (excl. chemotherapy and radiation therapy)Clinical nutritionInformation systems development methodologies and practiceMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 03, 2026
Early risk stratification of late-onset sepsis in very preterm infants by intestinal microbiota profiling: a multicenter case-control validation study.

|Dec 14, 2024
Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host-Microbiome-Metabolomic Signatures.

Mohammed Nabil Quraishi, Jonathan Cheesbrough, Peter Rimmer

|Apr 12, 2024
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.

Benjamin H Mullish, Blair Merrick, Mohammed Nabil Quraishi

|Aug 15, 2023
Establishing key performance indicators for inflammatory bowel disease in the UK.

Mohammed Nabil Quraishi, Elizabeth Dobson, Rachel Ainley

|Jul 14, 2023
Faecal Microbiota Transplantation [FMT] in the Treatment of Chronic Refractory Pouchitis: A Systematic Review and Meta-analysis.

Shafquat Zaman, Akinfemi Akingboye, Ali Yasen Y Mohamedahmed

|Mar 17, 2022
Insight from patients and healthcare professionals on the implementation of virtual clinics in patients with inflammatory bowel disease.

Aditi Kumar, Mohammed Nabil Quraishi, Shanika de Silva

Pageof 3

Frequent Collaborators

5 joint publications

Benjamin H Mullish

3 joint publications

Andrew D Beggs

2 joint publications

Jonathan Segal

2 joint publications

Animesh Acharjee